Archive of Oncology 2022 Volume 28, Issue 1, Pages: 7-12
https://doi.org/10.2298/AOO210205002P
Full text (
134 KB)
Special aspects of medical care for cancer patients during COVID-19 pandemic
Pavlushenko Mariia (Department of Oncology, O.O. Bogomolets National Medical University, Kyiv, Ukraine), marija.pawlushenko@gmail.com
Liubota Roman (Department of Oncology, O.O. Bogomolets National Medical University, Kyiv, Ukraine)
Vereshchako Roman (Department of Oncology, O.O. Bogomolets National Medical University, Kyiv, Ukraine)
Anikusko Nikolay (Municipal Clinical Oncological Centre, Kyiv, Ukraine)
Liubota Irina (Municipal Clinical Oncological Centre, Kyiv, Ukraine)
The biggest challenge for the World Health Organization today is the fight against the COVID-19 pandemic. The current situation prompted major adjustments in the system of cancer care. In this review, we investigate the aspects of cancer treatment and care during the pandemic, since in this setting oncological services face challenges in determining the feasibility of anticancer treatments while minimizing the risk of infection. Cancer patients are at a higher risk from COVID-19 disease. Therefore, oncological community is discussing on the priorities for providing cancer therapies and care and at the same time minimizing the risk of infection.
Keywords: COVID-19, pandemic, cancer, medical care
Show references
https://covid19.rnbo.gov.ua/
Thompson CK, Lee MK, Baker JL, Attai DJ, DiNome ML. Taking a Second Look at Neoadjuvant Endocrine Therapy for the Treatment of Early Stage Estrogen Receptor Positive Breast Cancer During the COVID-19 Outbreak. Ann Surg. 2020 Aug;272(2):e96-e97. doi: 10.1097/SLA.0000000000004027.
Ray U, Aziz F, Shankar A, Biswas AS, Chakraborty A. COVID-19: The Impact in Oncology Care. SN Compr Clin Med. 2020 Oct 23:1-10. doi: 10.1007/s42399- 020-00592-7.
Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020 Jul;21(7):904-913. doi: 10.1016/S1470-2045(20)30310-7.
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6.
Leung MST, Lin SG, Chow J, Harky A. COVID-19 and Oncology: Service transformation during pandemic. Cancer Med. 2020 Oct;9(19):7161-7171. doi: 10.1002/ cam4.3384.
Jindal V, Sahu KK, Gaikazian S, Siddiqui AD, Jaiyesimi I. Cancer treatment during COVID-19 pandemic. Med Oncol. 2020 May 29;37(7):58. doi: 10.1007/s12032- 020-01382-w.
Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, et al. STOPCOVID Investigators. Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. JAMA Intern Med. 2020 Jul 15;180(11):1-12. doi: 10.1001/jamainternmed.2020.3596.
Jones D, Neal RD, Duffy SRG, Scott SE, Whitaker KL, Brain K. Impact of the COVID- 19 pandemic on the symptomatic diagnosis of cancer: the view from primary care. Lancet Oncol. 2020 Jun;21(6):748-750. doi: 10.1016/S1470-2045(20)30242-4.
Zadnik V, Mihor A, Tomsic S, Zagar T, Bric N, Lokar K, et al. Impact of COVID-19 on cancer diagnosis and management in Slovenia - preliminary results. Radiol Oncol. 2020 Jul 29;54(3):329-334. doi: 10.2478/raon-2020-0048.
Earnshaw CH, Hunter HJA, McMullen E, Griffiths CEM, Warren RB. Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic. Br J Dermatol. 2020 Oct;183(4):792-794. doi: 10.1111/bjd.19267.
Minucci A, Scambia G, Santonocito C, Concolino P, Urbani A. BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic. Mol Biol Rep. 2020 Jun;47(6):4857-4860. doi: 10.1007/s11033-020-05479-3.
COVID19 Subcommittee of the O.R. Executive Committee at Memorial Sloan Kettering. Cancer Surgery and COVID19. Ann Surg Oncol. 2020 Jun;27(6):1713- 1716. doi: 10.1245/s10434-020-08462-1.
Gundavda MK, Gundavda KK. Cancer or COVID-19? A Review of Guidelines for Safe Cancer Care in the Wake of the Pandemic. SN Compr Clin Med. 2020 Nov 21:1-11. doi: 10.1007/s42399-020-00632-2.
Hartman HE, Sun Y, Devasia TP, Chase EC, Jairath NK, Dess RT, et al. Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic. JAMA Oncol. 2020 Dec 1;6(12):1881-1889. doi: 10.1001/jamaoncol.2020.5403.
Ueda M, Martins R, Hendrie PC, McDonnell T, Crews JR, Wong TL, et al. Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal. J Natl Compr Canc Netw. 2020 Mar 20:1-4. doi: 10.6004/ jnccn.2020.7560.
Sud A, Jones ME, Broggio J, Loveday C, Torr B, Garrett A, et al. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann Oncol. 2020 Aug;31(8):1065-1074. doi: 10.1016/j.annonc.2020.05.009.
Pramesh CS, Badwe RA. Cancer Management in India during Covid-19. N Engl J Med. 2020 May 14;382(20):e61. doi: 10.1056/NEJMc2011595.
Patt D, Gordan L, Diaz M, Okon T, Grady L, Harmison M, et al. Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors. JCO Clin Cancer Inform. 2020 Nov;4:1059-1071. doi: 10.1200/ CCI.20.00134.
Seth G, Sethi S, Bhattarai S, Saini G, Singh CB, Aneja R. SARS-CoV-2 Infection in Cancer Patients: Effects on Disease Outcomes and Patient Prognosis. Cancers (Basel). 2020 Nov 5;12(11):3266. doi: 10.3390/cancers12113266.
Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope. 2020 Jul;130(7):1787. doi: 10.1002/ lary.28692.
Madariaga A, McMullen M, Sheikh S, Kumar R, Liu FF, Zimmermann C, et al. COVID- 19 Testing in Patients with Cancer: Does One Size Fit All? Clin Cancer Res. 2020 Sep 15;26(18):4737-4742. doi: 10.1158/1078-0432.CCR-20-2224.
Passaro A, Peters S, Mok TSK, Attili I, Mitsudomi T, de Marinis F. Testing for COVID- 19 in lung cancer patients. Ann Oncol. 2020 Jul;31(7):832-834. doi: 10.1016/j. annonc.2020.04.002.
Cabezon-Gutierrez L, Custodio-Cabello S, Palka-Kotlowska M, Oliveros-Acebes E, Garcia-Navarro MJ, Khosravi-Shahi P. Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data. Cancer Treat Rev. 2020 Nov;90:102102. doi: 10.1016/j.ctrv.2020.102102.
Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, et al. COVID- 19 and Cancer Consortium. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020 Jun 20;395(10241):1907-1918. doi: 10.1016/S0140-6736(20)31187-9.
Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020 Jul;31(7):894-901. doi: 10.1016/j. annonc.2020.03.296.
Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. Cancer Discov. 2020 Jun;10(6):783-791. doi: 10.1158/2159-8290.CD-20-0422.
Lee LY, Cazier JB, Angelis V, Arnold R, Bisht V, Campton NA, et al. UK Coronavirus Monitoring Project Team, Kerr R, Middleton G. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020 Jun 20;395(10241):1919-1926. doi: 10.1016/S0140- 6736(20)31173-9.
Gosain R, Abdou Y, Singh A, Rana N, Puzanov I, Ernstoff MS. COVID-19 and Cancer: a Comprehensive Review. Curr Oncol Rep. 2020 May 8;22(5):53. doi: 10.1007/s11912-020-00934-7.
Vuagnat P, Frelaut M, Ramtohul T, Basse C, Diakite S, Noret A, et al. Institut Curie Breast Cancer and COVID Group, Bozec L, Paoletti X, Cottu P, Bidard FC. COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area. Breast Cancer Res. 2020 May 28;22(1):55. doi: 10.1186/s13058-020-01293-8.
Shoumariyeh K, Biavasco F, Ihorst G, Rieg S, Nieters A, Kern WV, Miething C, Duyster J, Engelhardt M, Bertz H. Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany. Cancer Med. 2020 Nov;9(22):8412-8422. doi: 10.1002/cam4.3460.